Nicholas Investment Partners, LP Immunocore Holdings PLC Transaction History

Nicholas Investment Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$60.14 - $75.36 $1.52 Million - $1.91 Million	25,296 Added 48.5%	77,455 $5.03 Million
Q4 2023 Feb 07, 2024	SELL	$42.85 - $69.5 $19.7 Million - $32 Million	-460,696 Reduced 89.83%	52,159 $3.56 Million
Q3 2023 Nov 13, 2023	BUY	$49.5 - $66.6 $25.2 Million - $33.8 Million	508,155 Added 10811.81%	512,855 $26.6 Million
Q2 2023 Aug 09, 2023	BUY	$48.54 - $61.64 $228,138 - $289,708	4,700 New	4,700 $281,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.